Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI (OI)

What is the purpose of this trial?

This is a prospective, multicenter, single-arm study in children 2 to 17 years of age with OI to evaluate efficacy and safety of denosumab.

Participation Guidelines

Ages: 2 - 17 years

Gender: Both

Amgen, Inc.

Start Date: 09/29/2017

End Date: 02/15/2018

Last Updated: 02/22/2018

Study HIC#: 1501015168

Get Involved

For more information about this study, contact:
Hollis Lowe
+1 203-785-6779

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Thomas Carpenter

Principal Investigator